| 000 | 01455 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250512023427.0 | ||
| 264 | 0 | _c19870401 | |
| 008 | 198704s 0 0 eng d | ||
| 022 | _a0270-3211 | ||
| 024 | 7 |
_a10.1002/tcm.1770060602 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMourelatos, D | |
| 245 | 0 | 0 |
_aEnhancement of cytogenetic damage by inhibitors of poly(ADP-ribose)polymerase in human lymphocytes exposed to antineoplastics in vivo and in vitro. _h[electronic resource] |
| 260 |
_bTeratogenesis, carcinogenesis, and mutagenesis _c1986 |
||
| 300 |
_a485-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aBenzamides _xpharmacology |
| 650 | 0 | 4 |
_aBromodeoxyuridine _xpharmacology |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 |
_aColchicine _xpharmacology |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aLymphocytes _xcytology |
| 650 | 0 | 4 |
_aMelphalan _xpharmacology |
| 650 | 0 | 4 | _aMutagens |
| 650 | 0 | 4 | _aPoly(ADP-ribose) Polymerase Inhibitors |
| 650 | 0 | 4 |
_aSister Chromatid Exchange _xdrug effects |
| 650 | 0 | 4 |
_aThiotepa _xpharmacology |
| 700 | 1 | _aKourakis, A | |
| 700 | 1 | _aKoliouskas, D E | |
| 700 | 1 | _aHatzitheodoridou, P | |
| 700 | 1 | _aDozi-Vassiliades, J | |
| 773 | 0 |
_tTeratogenesis, carcinogenesis, and mutagenesis _gvol. 6 _gno. 6 _gp. 485-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/tcm.1770060602 _zAvailable from publisher's website |
| 999 |
_c2887212 _d2887212 |
||